Table 8 Univariate regression analysis of factors influencing clinical outcomes in pediatric PSH patients
Predictor | Univariate regression analysis | |||
|---|---|---|---|---|
Estimate | 95% Confidence Interval | p | ||
Lower | Upper | |||
Age | 0.221 | -0.0333 | 0.475 | 0.088 |
Female patients | -18.13 | -5651.32 | 5615.062 | 0.995 |
Term | -0.981 | -3.47 | 1.51 | 0.44 |
Global developmental delay | 0.47 | -1.84 | 2.78 | 0.69 |
Positive History of brain insult | -1.79 | -4.08 | 0.501 | 0.126 |
Age of onset | 0.234 | -0.0626 | 0.531 | 0.122 |
Traumatic etiology | -16.74 | -6408.81 | 6375.327 | 0.996 |
Frequency (episodes per day) | -0.42 | -1.14 | 0.298 | 0.252 |
Duration of attacks per day in minutes | 0.00534 | -6.97e − 4 | 0.0114 | 0.083 |
PSH-AM score | -0.115 | -0.46 | 0.23 | 0.513 |
Onset of diagnosis | 0.38 | 0.0303 | 0.73 | 0.033 |
Abortive medications | Â | Â | Â | Â |
Morphine use | 0.811 | -1.1 | 2.724 | 0.406 |
Clonidine use | -0.577 | -2.49 | 1.331 | 0.553 |
Benzodiazepine use | 0.17 | -2.16 | 2.5 | 0.886 |
Acetaminophen use | -0.86 | -3.16 | 1.436 | 0.463 |
Preventive medications | Â | Â | Â | Â |
Gabapentin use | 0.325 | -1.99 | 2.644 | 0.783 |
Baclofen use | -1.1 | -3.39 | 1.193 | 0.347 |